Results 11 to 20 of about 6,998 (166)

Atypical hemolytic uremic syndrome [PDF]

open access: yesOrphanet Journal of Rare Diseases, 2011
Hemolytic uremic syndrome (HUS) is defined by the triad of mechanical hemolytic anemia, thrombocytopenia and renal impairment. Atypical HUS (aHUS) defines non Shiga-toxin-HUS and even if some authors include secondary aHUS due to Streptococcus pneumoniae
Frémeaux-Bacchi Véronique   +1 more
doaj   +6 more sources

Atypical hemolytic uremic syndrome [PDF]

open access: yesRenal Replacement Therapy, 2017
Atypical hemolytic uremic syndrome (aHUS) is a thrombotic microangiopathy (TMA) characterized by microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure.
Yoko Yoshida   +2 more
doaj   +2 more sources

Pediatric Atypical Hemolytic Uremic Syndrome Advances [PDF]

open access: yesCells, 2021
Atypical hemolytic uremic syndrome (aHUS) is a rare disorder characterized by dysregulation of the alternate pathway. The diagnosis of aHUS is one of exclusion, which complicates its early detection and corresponding intervention to mitigate its high ...
Rupesh Raina   +9 more
doaj   +3 more sources

Atypical hemolytic uremic syndrome: a brief review [PDF]

open access: yesHematology Reports, 2017
Atypical hemolytic uremic syndrome (aHUS) is a disease characterized by the triad of microangiopathic hemolytic anemia, thrombocytopenia and acute kidney injury.
Kuixing Zhang   +3 more
doaj   +5 more sources

Difficulties in diagnosing atypical hemolytic uremic syndrome [PDF]

open access: yesСибирский научный медицинский журнал, 2020
The paper presents the case of clinical observation of a patient with atypical hemolytic-uremic syndrome (aHUS). aHUS is a disease characterized by an unfavorable prognosis (severe or catastrophic course with rapid development of terminal renal or multi ...
N. V. Fomina   +5 more
doaj   +2 more sources

Atypical hemolytic uremic syndrome [PDF]

open access: yesHematology, 2016
AbstractAtypical hemolytic uremic syndrome (aHUS) is a thrombotic microangiopathy (TMA) that affects multiple organs and the kidneys in particular. aHUS can be sporadic or familial and is most commonly caused by dysregulation of the alternative complement pathway.
Ali, Nayer, Arif, Asif
openaire   +4 more sources

Atypical Hemolytic Uremic Syndrome

open access: yesSeminars in Nephrology, 2013
Hemolytic uremic syndrome (HUS) is a triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure. The atypical form of HUS is a disease characterized by complement overactivation. Inherited defects in complement genes and acquired autoantibodies against complement regulatory proteins have been described.
Kavanagh D, Goodship TH, Richards A
openaire   +6 more sources

Pregnancy-Induced Atypical Hemolytic Uremic Syndrome. [PDF]

open access: yesCureus
Atypical hemolytic uremic syndrome (aHUS) is a rare form of thrombotic microangiopathy that causes anemia, thrombocytopenia, and acute renal failure. In aHUS, a triggering event can lead to dysregulation of the complement immune system, leading to a cascade of events resulting in clot formation, capillary thrombosis, and renal dysfunction.
Den Boef A   +4 more
europepmc   +3 more sources

The genetics of atypical hemolytic uremic syndrome [PDF]

open access: yesMedizinische Genetik, 2018
Abstract Atypical hemolytic uremic syndrome (aHUS) is a disorder characterized by thrombocytopenia and microangiopathic hemolytic anemia due to endothelial injury. aHUS is felt to be caused by defective complement regulation due to underlying genetic mutations in complement regulators or activators, most often of the alternative pathway.
Feitz, W.JC.   +4 more
openaire   +3 more sources

Atypical Hemolytic Uremic Syndrome

open access: yesPediatric Clinics of North America, 2018
Atypical hemolytic uremic syndrome is a rare life-threatening disease of unregulated complement activation. Untreated, the prognosis is generally poor; more than one-half of patients die or develop end-stage renal disease within 1 year. Atypical hemolytic uremic syndrome is characterized by thrombotic microangiopathy with evidence of hemolysis ...
Bradley P. Dixon, Ralph A. Gruppo
  +7 more sources

Home - About - Disclaimer - Privacy